Navin Fluorine International Ltd
Navin Fluorine International Ltd
CommoditiesNavin Fluorine International Ltd is primary engaged in producing refrigeration gases, inorganic fluorides, specialty organofluorines and offers contract research and manufacturing services.[1] Its portfolio includes 50+ fluorinated compounds developed over the years.[2]
Navin Fluorine shows exceptional profit growth of 132% TTM and strong analyst support with 76% buy ratings, but the stock trades at a steep PE of 56.4x and 9.42x book value, suggesting much of the growth is already priced in. Working capital deterioration from 83 to 178 days warrants monitoring before adding positions.
Key Fundamentals
MidcapSpecialty ChemicalsChemicalsTechnical Indicators
Key Insights
Strengths
3- Company is expected to give good quarter
- Company has delivered good profit growth of 22.2% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 17.1%
Weaknesses
2- Stock is trading at 9.93 times its book value
- Working capital days have increased from 82.8 days to 178 days
Growth Rate
AI Analysis — Bull vs Bear
Navin Fluorine shows exceptional profit growth of 132% TTM and strong analyst support with 76% buy ratings, but the stock trades at a steep PE of 56.4x and 9.42x book value, suggesting much of the growth is already priced in. Working capital deterioration from 83 to 178 days warrants monitoring before adding positions.
- Compounded profit growth of 132% TTM indicates a significant earnings inflection and operational leverage kicking in
- 76% of analysts (19 out of 25) rate the stock a Buy, reflecting strong institutional conviction
- Consistent 5-year profit CAGR of 22% demonstrates durable earnings compounding ability
- ROE improved to 20% in the last year from a 5-year average of 15%, signaling improving capital efficiency
- Compounded sales growth of 41% TTM shows strong demand tailwinds in specialty fluorine chemicals
- 10-year stock CAGR of 34% reflects long-term wealth creation track record
- 5-year sales CAGR of 23% outpaces the broader specialty chemicals sector average of 12-15%
- Company expected to deliver a good upcoming quarter per screener consensus
- PE ratio of 56.4x is expensive even by specialty chemicals standards, leaving limited margin of safety
- Price-to-book of 9.42x implies the market is pricing in years of future growth already
- Working capital days ballooned from 83 to 178 days, indicating potential cash conversion cycle stress
- Dividend yield of just 0.21% provides negligible income cushion during any price correction
- Stock has already rallied 60% in the past 1 year, raising risk of mean reversion
- 16% of analysts (4 out of 25) rate the stock a Sell, a non-trivial bearish minority
- Dividend payout ratio of only 17.1% means limited shareholder returns relative to earnings
- ROE and ROCE data currently unavailable for latest period, reducing visibility on return sustainability
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Hybrid power SPV investment Jun 5
Navin Fluorine Advanced Sciences Limited investing ₹5.50 crore for a 26% stake in Pro-Zeal Green Power Twenty Pvt Ltd, securing a 15-year power supply agreement for 5MW hybrid power at the Dahej Unit.
TL;DR: Navin Fluorine is taking steps to secure long-term renewable energy supply for its Dahej operations, which should provide cost stability and support ESG positioning. No headwinds surfaced in recent coverage. With limited news flow, the outlook remains steady, and the green energy tie-up signals management focus on operational efficiency going forward.
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 697 | 491 | 472 | 500 | 602 | 524 | 519 | 606 | 701 | 725 | 758 | 892 | 938 |
| Expenses | 495 | 377 | 373 | 424 | 492 | 423 | 411 | 459 | 522 | 519 | 512 | 585 | 617 |
| Operating Profit | 202 | 114 | 98 | 76 | 110 | 100 | 107 | 147 | 179 | 207 | 246 | 308 | 321 |
| OPM % | 29% | 23% | 21% | 15% | 18% | 19% | 21% | 24% | 26% | 29% | 32% | 34% | 34% |
| Other Income | 4 | 8 | 23 | 64 | 13 | 10 | 11 | 10 | 12 | 14 | 18 | -5 | 31 |
| Interest | 14 | 19 | 20 | 18 | 17 | 16 | 14 | 20 | 28 | 30 | 30 | 28 | 29 |
| Depreciation | 8 | 21 | 24 | 25 | 26 | 27 | 28 | 30 | 35 | 35 | 37 | 36 | 41 |
| PBT | 184 | 82 | 77 | 97 | 79 | 68 | 77 | 108 | 127 | 155 | 198 | 238 | 282 |
| Tax % | 26% | 25% | 22% | 20% | 11% | 25% | 23% | 23% | 25% | 24% | 25% | 22% | 25% |
| Net Profit | 136 | 62 | 61 | 78 | 70 | 51 | 59 | 84 | 95 | 117 | 148 | 185 | 213 |
| EPS in Rs | 27.5 | 12.41 | 12.22 | 15.74 | 14.19 | 10.32 | 11.86 | 16.86 | 19.15 | 23.62 | 28.96 | 36.18 | 41.48 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 592 | 680 | 742 | 913 | 996 | 1,062 | 1,179 | 1,453 | 2,077 | 2,065 | 2,349 | 3,314 |
| Expenses | 519 | 561 | 582 | 693 | 777 | 794 | 870 | 1,098 | 1,527 | 1,666 | 1,816 | 2,232 |
| Operating Profit | 72 | 118 | 159 | 220 | 219 | 268 | 309 | 356 | 550 | 399 | 534 | 1,082 |
| OPM % | 12% | 17% | 21% | 24% | 22% | 25% | 26% | 24% | 26% | 19% | 23% | 33% |
| Other Income | 29 | 23 | 55 | 88 | 34 | 29 | 94 | 38 | 36 | 107 | 44 | 59 |
| Interest | 3 | 4 | 3 | 1 | 1 | 2 | 2 | 2 | 28 | 75 | 78 | 118 |
| Depreciation | 20 | 22 | 30 | 40 | 28 | 37 | 44 | 48 | 63 | 96 | 119 | 149 |
| PBT | 78 | 116 | 182 | 266 | 224 | 258 | 358 | 344 | 496 | 336 | 380 | 873 |
| Tax % | 26% | 28% | 25% | 32% | 34% | -56% | 31% | 24% | 24% | 19% | 24% | 24% |
| Net Profit | 58 | 84 | 137 | 180 | 149 | 409 | 258 | 263 | 375 | 270 | 289 | 664 |
| EPS in Rs | 11.18 | 17.08 | 27.88 | 36.43 | 30.15 | 82.57 | 52.02 | 53.09 | 75.68 | 54.56 | 58.19 | 129 |
| Div. Payout % | 29% | 25% | 23% | 27% | 26% | 13% | 21% | 21% | 16% | 27% | 12% | 12% |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 578 | 636 | 825 | 974 | 1,063 | 1,402 | 1,624 | 1,834 | 2,175 | 2,373 | 2,616 | 3,964 |
| Borrowings | 61 | 82 | 19 | 13 | 4 | 1 | 25 | 121 | 861 | 1,368 | 1,466 | 1,272 |
| Other Liabilities | 203 | 228 | 324 | 259 | 231 | 215 | 239 | 420 | 484 | 626 | 738 | 1,133 |
| Total Liabilities | 852 | 955 | 1,177 | 1,256 | 1,307 | 1,629 | 1,898 | 2,385 | 3,529 | 4,377 | 4,830 | 6,379 |
| Fixed Assets | 274 | 375 | 561 | 428 | 430 | 529 | 540 | 556 | 1,646 | 1,875 | 2,736 | 3,324 |
| CWIP | 60 | 20 | 17 | 20 | 39 | 39 | 95 | 742 | 279 | 711 | 355 | 143 |
| Investments | 171 | 170 | 239 | 428 | 427 | 195 | 99 | 118 | 44 | 495 | 480 | 1,229 |
| Other Assets | 346 | 390 | 360 | 380 | 410 | 866 | 1,163 | 969 | 1,561 | 1,296 | 1,259 | 1,683 |
| Total Assets | 852 | 955 | 1,177 | 1,256 | 1,307 | 1,629 | 1,898 | 2,385 | 3,529 | 4,377 | 4,830 | 6,379 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1 | 76 | 92 | 169 | 90 | 157 | 237 | 75 | -64 | 750 | 571 | 894 |
| Investing | 3 | -53 | -16 | -136 | -24 | 85 | -237 | -172 | -656 | -1,094 | -511 | -1,235 |
| Financing | -21 | -17 | -67 | -39 | -68 | -81 | -45 | 42 | 658 | 336 | -47 | 344 |
| Net Cash Flow | -17 | 6 | 10 | -6 | -3 | 161 | -45 | -56 | -61 | -8 | 13 | 3 |
| Free Cash Flow | -61 | 58 | -84 | 121 | 29 | 59 | 147 | -501 | -819 | 72 | 4 | 404 |
| CFO/OP | 28 | 87 | 78 | 100 | 74 | 76 | 71 | 43 | 8 | 196 | 122 | 83 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 74 | 81 | 68 | 62 | 63 | 75 | 88 | 90 | 99 | 91 | 90 | 83 |
| Inventory Days | 96 | 89 | 136 | 110 | 91 | 127 | 129 | 149 | 197 | 150 | 117 | 118 |
| Days Payable | 113 | 112 | 94 | 92 | 58 | 79 | 77 | 85 | 103 | 122 | 118 | 140 |
| Cash Conversion Cycle | 57 | 57 | 110 | 80 | 96 | 123 | 140 | 154 | 193 | 119 | 89 | 61 |
| Working Capital Days | 39 | 37 | 4 | 43 | 58 | 88 | 113 | 109 | 140 | 45 | 25 | 178 |
| ROCE % | 11% | 17% | 22% | 29% | 21% | 21% | 22% | 19% | 20% | 11% | 12% | 21% |
Documents
Frequently Asked Questions about Navin Fluorine International Ltd
What does Navin Fluorine International Ltd do?
Where is Navin Fluorine International Ltd (NAVINFLUOR) listed?
Which sector does Navin Fluorine International Ltd belong to?
What is the market capitalisation of Navin Fluorine International Ltd?
What is the PE ratio of Navin Fluorine International Ltd?
What is the 52-week high and low of Navin Fluorine International Ltd?
Does Navin Fluorine International Ltd pay dividends?
What is the Return on Equity (ROE) of Navin Fluorine International Ltd?
How can I research Navin Fluorine International Ltd on Tapetide?
Company Information
Navin Fluorine International Ltd is primary engaged in producing refrigeration gases, inorganic fluorides, specialty organofluorines and offers contract research and manufacturing services.[1] Its portfolio includes 50+ fluorinated compounds developed over the years.[2]